Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:administeredBy |
Rh-negative pregnant women
|
| gptkbp:alsoKnownAs |
gptkb:Rho(D)_immune_globulin
|
| gptkbp:approvedBy |
gptkb:FDA
1968 |
| gptkbp:ATCCode |
gptkb:J06BB01
|
| gptkbp:chemicalClass |
immune response
|
| gptkbp:contains |
anti-D antibodies
|
| gptkbp:contraindication |
hypersensitivity to human immunoglobulins
Rh-positive individuals |
| https://www.w3.org/2000/01/rdf-schema#label |
Rhogam
|
| gptkbp:indication |
after abortion or miscarriage
after amniocentesis after delivery of an Rh-positive infant after trauma during pregnancy |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Kedrion_Biopharma
|
| gptkbp:pregnancyCategory |
C
|
| gptkbp:prevention |
formation of anti-D antibodies in Rh-negative mothers
|
| gptkbp:routeOfAdministration |
intramuscular injection
|
| gptkbp:sideEffect |
fever
allergic reaction injection site soreness |
| gptkbp:usedFor |
prevention of Rh immunization
prevention of hemolytic disease of the newborn |
| gptkbp:bfsParent |
gptkb:Rho(D)_immune_globulin
|
| gptkbp:bfsLayer |
8
|